• Explore /
  • Poster
  • / Retrospective analysis of adherence and persistence of encorafenib in combination with cetuximab among patients with BRAF metastatic CRC in the United States (US).

Retrospective analysis of adherence and persistence of encorafenib in combination with cetuximab among patients with BRAF metastatic CRC in the United States (US).

Abstract Poster

Authors

null

Aparna Raj Parikh

Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Aparna Raj Parikh , Maria Cecilia Vieira , Michelle Silver , Andrew Rava , Reina Rau , Benjamin Li

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 64)

DOI

10.1200/JCO.2024.42.3_suppl.64

Abstract #

64

Poster Bd #

E7

Abstract Disclosures

Similar Posters

First Author: Aparna Raj Parikh

First Author: Guglielmo Vetere

First Author: Samuel J Klempner

First Author: Tharani Krishnan